Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2018

View Archived Issues

Fighting senescence boosts immunity

MANF rescues dopaminergic neurons in C. elegans alpha-synuclein models of Parkinson's disease

TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases

Immunity is for babies

SOM Biotech initiates phase IIa trial of repurposed drug

THX-160 shows promise in preclinical studies for acute and chronic pain

Selective PDE4D PET ligands developed to study depression and cognitive impairment

Orion Biotechnology earns grant to support development of microbicide candidate

Researchers unveil new biomarkers of treatment-free survival in CLL

Favorable review of safety data from second dose cohort in MAGE-A10 SPEAR T-cell study

Takeda and Ovid announce expansion of the clinical program for TAK-935

Topline data presented from phase III trial of tanezumab

Positive interim data presented from a phase II/III study of marzeptacog alfa

Beta cells make and secrete autoimmune peptides

Chinese phase III trial of GV-971 in Alzheimer's disease meets primary endpoint

RPL28 gene polymorphism tied to reduced survival in FOLFIRI-treated mCRC patients

KDDF grant will support evaluation of Hyleukin-7 with Keytruda in triple-negative breast cancer

Incyte studies INCB-054707 for hidradenitis suppurativa in phase II trial

Vyriad collaborates with Merck KGaA and Pfizer to study Voyager-V1 with avelumab

FDA approves Kisqali for HR-positive HER-negative advanced or metastatic breast cancer

Phase III study of subcutaneous vedolizumab in ulcerative colitis meets primary endpoint

Daiichi Sankyo and collaborator patent TNSALP inhibitors

Aquinnah Pharmaceuticals divulges TDP-43 aggregation inhibitors

Nampt inhibition with OT-82 shows promise in xenograft leukemia models

Incyte presents PD-1/PD-L1 interaction inhibitors

Global Blood Therapeutics patents EHMT2 inhibitors

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...